Infinity Medical

About

Portfolio · 4

Nanomedic Technologies

Portable Wound Treatment System

1 round $750K committed Latest: 2022-02

Genoox

Genomic Data Management Platform

1 round $8.0M committed Latest: 2021-05

Cynerio

Cybersecurity for Healthcare Providers

1 round $30.0M committed Latest: 2021-05

Biobeat

24 Hour Cuff-less Blood Pressure Monitoring

1 round Latest: 2021-02

Investment activity

2 portfolio exits on record.

Q&A

What is Infinity Medical's primary investment focus?

Infinity Medical is a Limited Partnership that invests in the digital health sector, focusing on breakthrough stage companies.

Which stages does Infinity Medical typically invest in?

Infinity Medical typically invests in Seed and A Round stages.

Can you name some of Infinity Medical's notable portfolio companies?

Infinity Medical's portfolio includes Biobeat, which focuses on 24-hour cuff-less blood pressure monitoring, and Theranica, which develops neuromodulation-based patches for migraine relief.

What are some recent exits for Infinity Medical?

Infinity Medical has seen two notable exits: Cynerio was acquired by Axonius for $180M in July 2025, and Genoox was acquired by Qiagen for $80M in May 2025.

Who are the key founders at Infinity Medical?

The key founders at Infinity Medical include Amir Gal Or, who serves as Chairman of the investment committee, Yuval Bloch, the CEO, and Einav Adiv-Berar, a Director.

What is Infinity Medical's geographic focus for investments?

Infinity Medical is based in Tel Aviv-Yafo, Israel, and focuses its investments within Israel.

What is Infinity Medical's collaboration model?

Infinity Medical operates as a unique collaboration with Ichilov-Tech and IBM Israel.

What sectors has Infinity Medical seen exits in?

Infinity Medical has seen exits in both the Health Tech & Life Sciences sector and the Cyber Security sector.